Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) is a leading cause of hospitalization in infants. That’s why it is important to protect this population.
Christine & Tom Burlinson with their baby daughter, Aria, who was hospitalized with RSV

Did You Know?

Bronchiolitis and pneumonia

Severe lower respiratory tract infections that can be caused by RSV.1

90%

Percentage of children infected with RSV in the first two years of life.2

EFCNI

We partner with the European Foundation for the Care of Newborn Infants to raise RSV awareness.
Explore site

Is RSV Disease Predictable?

Are all infants at risk from RSV?

This factsheet will help you better understand the challenges around RSV in newborns and infants and highlights the importance to protect this population.

Download
Baptiste, hospitalized with RSV

About RSV and Its Risks

RSV is a common, contagious seasonal virus that will infect nearly all children by their second birthday.3 While symptoms often appear as a cold, RSV is the most common cause of lower respiratory tract infections and a leading cause of hospitalization in infants, even healthy infants born at term.4

Read the article

Importance of Immunization

Raising awareness of RSV is a first step toward its prevention. The majority of infants hospitalized with RSV are born healthy and at term, with 50 percent of hospitalizations occurring in infants born prior to the RSV season.5, 6, 7 

All About RSV

Sanne’s Story

Hear from a mother about her family’s experience with RSV

Dina and Winnie’s RSV Story

Dina describes her baby daughter’s challenging journey with RSV

The Promise initiative

We’re pleased to join forces to expand RSV prevention.
Explore site

Explore More

Advancing the Science of RSV

Read the article

The Burden of RSV: How the Scientific Community Can Help

Read the article

From Setbacks to Solutions: Innovations and Challenges in RSV Research

Explore site

References

  1. Shi T, McAllister DA, O'Brien KL, et al; RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946-958
  2. Glezen WP et al. Risk of primary infection and reinfection with respiratory syncytial virus.  Am J Dis Child. 1986; 140 (6); 543-546
  3. Respiratory Syncytial Virus Infection (RSV): Infants and Young Children. Centers for Disease Control and Prevention. https://www.cdc.gov/rsv/high-risk/infants-young-children.html. Accessed March 2023.
  4. Arriola CS, Kim L, Langley G, Anderson EJ, Openo K, Martin AM, et al. Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15. Journal of the Pediatric Infectious Diseases Society. 2020;9(5):587-95.
  5. Yu Jianxing, et al. Respiratory syncytial Virus Seasonality, Beijing, China, 2007-2015. Emerg Infect Dis. 2019;25(6):1127–1135
  6. Kobayashi Yasuhiro, et al. Epidemiology of respiratory syncytial virus in Japan : A nationwide claims database analysis. Ped Intl. 2021;0:1-7
  7. Reeves RM et al. Burden of hospital admissions caused by respiratory syncytial virus (RSV) in infants in England: A data linkage modelling study. J Infect. 2019;78(6):468-475

Page updated August 2023 

MAT-GLB-2001225 v7 – 08/2023